Skip to main content
Signal8
Madaus Martin D profile photo

Martin D. Madaus

CIK: 0001310268

Transaction Breakdown

Open Market Buys (P)3 (17.6%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)10 (58.8%)

Compensation grants

Other (G, F, J, C, D, …)4 (23.5%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (5)

Azenta, Inc. logo
AZTA

Azenta, Inc.

Officer
HAEMONETICS CORP logo
HAE

HAEMONETICS CORP

Director
REPLIGEN CORP logo
RGEN

REPLIGEN CORP

Director
HOLOGIC INC logo
HOLX

HOLOGIC INC

Director
Quanterix Corp logo
QTRX

Quanterix Corp

Director

Discretionary Trading P&L

Holdings

Transaction History (17 total)

  • Azenta, Inc. logo
    AZTA

    Azenta, Inc.

    Oct 22, 2026
    Tax Payment(F)
    Direct
    1.3K shares at avg. $36.01$47K
  • Azenta, Inc. logo
    AZTA

    Azenta, Inc.

    Sep 22, 2026
    Tax Payment(F)
    Direct
    1.5K shares at avg. $34.28$50K
  • Azenta, Inc. logo
    AZTA

    Azenta, Inc.

    Sep 14, 2026
    Award(A)
    Direct
    36.7K shares-
  • HAEMONETICS CORP logo
    HAE

    HAEMONETICS CORP

    Jul 24, 2026
    Award(A)
    Direct
    2.5K shares-
  • REPLIGEN CORP logo
    RGEN

    REPLIGEN CORP

    May 14, 2026
    Award(A)
    Direct
    995 shares-
  • HOLOGIC INC logo
    HOLX

    HOLOGIC INC

    Apr 7, 2026
    Disposition(D)
    Direct
    5.4K shares-
  • HOLOGIC INC logo
    HOLX

    HOLOGIC INC

    Apr 7, 2026
    Disposition(D)
    Indirect
    5.4K shares-
  • HOLOGIC INC logo
    HOLX

    HOLOGIC INC

    Feb 26, 2026
    Award(A)
    Direct
    3.2K shares-
  • Azenta, Inc. logo
    AZTA

    Azenta, Inc.

    Feb 5, 2026
    Award(A)

    Restricted Stock Unit

    Direct
    5.7K shares-
  • REPLIGEN CORP logo
    RGEN

    REPLIGEN CORP

    Aug 8, 2025
    Purchase(P)
    Indirect
    1.8K shares at avg. $112.13$202K
  • REPLIGEN CORP logo
    RGEN

    REPLIGEN CORP

    May 15, 2025
    Award(A)
    Direct
    973 shares-
  • HOLOGIC INC logo
    HOLX

    HOLOGIC INC

    May 7, 2025
    Purchase(P)
    Indirect
    5.4K shares at avg. $55.24$301K
  • HOLOGIC INC logo
    HOLX

    HOLOGIC INC

    Feb 26, 2025
    Award(A)
    Direct
    1.9K shares-
  • Azenta, Inc. logo
    AZTA

    Azenta, Inc.

    Feb 7, 2025
    Award(A)

    Restricted Stock Unit

    Direct
    4K shares-
  • Quanterix Corp logo
    QTRX

    Quanterix Corp

    Jan 2, 2025
    Award(A)
    Direct
    7.4K shares-
  • HOLOGIC INC logo
    HOLX

    HOLOGIC INC

    Dec 9, 2024
    Award(A)
    Direct
    342 shares-
  • Azenta, Inc. logo
    AZTA

    Azenta, Inc.

    Nov 19, 2024
    Purchase(P)
    Direct
    4.9K shares at avg. $40.77$201K

1-17 of 17

About Madaus Martin D

Madaus Martin D (SEC CIK 0001310268) files insider reports with the SEC as Interim CEO of Azenta, Inc. (AZTA), Director of HAEMONETICS CORP (HAE) and Director of REPLIGEN CORP (RGEN). Signal8 also holds filings tied to 2 other companies.

Signal8 holds 19 ownership filings by Madaus Martin D (2 Form 3, 17 Form 4), filed between Nov 19, 2024 and Oct 23, 2026. Those filings report 17 transactions, from Nov 19, 2024 to Oct 22, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Madaus Martin D's filings is in BURLINGTON, MA.

Recent filings by Madaus Martin D

  • Oct 22, 2026: Tax withholding of AZTA shares (Form 4, code F).
  • Sep 22, 2026: Tax withholding of AZTA shares (Form 4, code F).
  • Sep 14, 2026: Grant or award of AZTA shares (Form 4, code A).
  • Jul 24, 2026: Grant or award of HAE shares (Form 4, code A).
  • May 14, 2026: Grant or award of RGEN shares (Form 4, code A).

Other insiders filing for Azenta, Inc. (AZTA)

How to read Form 4 transaction codes